Beijing Sunho Pharmaceutical Co (BJSE:920017) Shares Outstanding (EOP): 123.2 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920017 Beijing Sunho Pharmaceutical Co Ltd BJSE:920017
80 GF Score
Price ¥15.67
GF Value ¥15.19
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Beijing Sunho Pharmaceutical Co Shares Outstanding (EOP)?

Beijing Sunho Pharmaceutical Co BJSE:920017 80 Shares Outstanding (EOP) is 123.2 Mil as of Jun. 2026. GuruFocus rates BJSE:920017 with a GF Score™ of 80/100 and a GF Value™ of ¥15.19 (Fairly Valued). The stock has 2 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Beijing Sunho Pharmaceutical Co's shares outstanding for the quarter that ended in Jun. 2026 was 123.2 Mil.

Beijing Sunho Pharmaceutical Co's quarterly shares outstanding stayed the same from Mar. 2026 (123.2 Mil) to Jun. 2026 (123.2 Mil).

Beijing Sunho Pharmaceutical Co's annual shares outstanding increased from Dec. 2024 (120.5 Mil) to Dec. 2025 (123.2 Mil). It means Beijing Sunho Pharmaceutical Co issued new shares from Dec. 2024 to Dec. 2025 .


Beijing Sunho Pharmaceutical Co  (BJSE:920017) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Beijing Sunho Pharmaceutical Co Shares Outstanding (EOP) Related Terms


Beijing Sunho Pharmaceutical Co Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Beijing Sunho Pharmaceutical Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Sunho Pharmaceutical Co Shares Outstanding (EOP) Chart

Beijing Sunho Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 122.58 122.58 120.39 120.49 123.16

Beijing Sunho Pharmaceutical Co Quarterly Data
Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.49 123.16 123.16 123.16 123.16

BJSE:920017 vs ZTS: Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Sunho Pharmaceutical Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Sunho Pharmaceutical Co Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Sunho Pharmaceutical Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Beijing Sunho Pharmaceutical Co's Shares Outstanding (EOP) falls into.


BJSE:920017
80GF Score
Beijing Sunho Pharmaceutical Co Ltd BJSE:920017
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Sunho Pharmaceutical Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 123.2 Mil mean?
Beijing Sunho Pharmaceutical Co (BJSE:920017) has a Shares Outstanding (EOP) of 123.2 Mil as of Jun. 2026. The total shares a company has outstanding, at period-end. View historical data on Beijing Sunho Pharmaceutical Co and its competitors.
Is Beijing Sunho Pharmaceutical Co's Shares Outstanding (EOP) too high?
Beijing Sunho Pharmaceutical Co's current Shares Outstanding (EOP) is 123.2 Mil. Overall, Beijing Sunho Pharmaceutical Co has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Sunho Pharmaceutical Co's Shares Outstanding (EOP) compare to ZTS?
Beijing Sunho Pharmaceutical Co's Shares Outstanding (EOP) of 123.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Beijing Sunho Pharmaceutical Co and its competitors. Beijing Sunho Pharmaceutical Co's current Shares Outstanding (EOP) is 123.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Sunho Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Sunho Pharmaceutical Co (BJSE:920017) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.19, compared to a current price of ¥15.67 — trading 3.2% above its estimated fair value. The current Shares Outstanding (EOP) is 123.2 Mil. Beijing Sunho Pharmaceutical Co's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Beijing Sunho Pharmaceutical Co (BJSE:920017), the current Shares Outstanding (EOP) is 123.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Sunho Pharmaceutical Co (BJSE:920017) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Sunho Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥15.67 is trading 3.2% above its estimated GF Value™ of ¥15.19. GuruFocus considers Beijing Sunho Pharmaceutical Co to be Fairly Valued.

Key valuation signals for BJSE:920017:

  • Shares Outstanding (EOP): 123.2 Mil
  • GF Value™: ¥15.19 vs. price of ¥15.67 (3.2% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the BJSE:920017 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beijing Sunho Pharmaceutical Co Business Description

Address No. 18, Zhonghe Street, Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Beijing Sunho Pharmaceutical Co Ltd engages in the research and development, production, and sales of pharmaceutical preparations while providing CMC/CMO integrated services for pharmaceutical preparation manufacturers and drug R&D enterprises. The company produces small-volume injections, freeze-dried powder injections, hard capsules, tablets, and other products. The company's main products included: compound digestive enzyme capsules, piracetam (small injection and powder injection), and oxalic acid acetate.
80GF Score

Get the complete analysis for BJSE:920017

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.67
Price
¥15.19
GF Value